Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 09, 2023

SELL
$31.15 - $33.39 $142,199 - $152,425
-4,565 Reduced 12.95%
30,686 $0
Q3 2022

Nov 04, 2022

SELL
$30.9 - $33.55 $18,323 - $19,895
-593 Reduced 1.65%
35,251 $1.11 Million
Q2 2022

Aug 01, 2022

SELL
$23.75 - $31.69 $92,387 - $123,274
-3,890 Reduced 9.79%
35,844 $1.09 Million
Q1 2022

May 12, 2022

SELL
$19.97 - $26.94 $4,493 - $6,061
-225 Reduced 0.56%
39,734 $1.03 Million
Q4 2021

Jan 31, 2022

BUY
$17.46 - $21.61 $697,684 - $863,513
39,959 New
39,959 $815,000

Others Institutions Holding VIVO

About MERIDIAN BIOSCIENCE INC


  • Ticker VIVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 43,748,000
  • Description
  • Meridian Bioscience, Inc., a life science company, develops, manufactures, distributes, and sells diagnostic test kits primarily for gastrointestinal and respiratory infectious diseases, and elevated blood lead levels worldwide. The company operates through Diagnostics and Life Science segments. The Diagnostics segment offers testing platforms, ...
More about VIVO
Track This Portfolio

Track Yousif Capital Management, LLC Portfolio

Follow Yousif Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Yousif Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Yousif Capital Management, LLC with notifications on news.